000 | 01860 a2200517 4500 | ||
---|---|---|---|
005 | 20250516141506.0 | ||
264 | 0 | _c20130906 | |
008 | 201309s 0 0 eng d | ||
022 | _a1460-2180 | ||
024 | 7 |
_a10.1093/carcin/bgt078 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRahman, Md Mujibur | |
245 | 0 | 0 |
_aDiscovery of potential targets of selenomethionine-mediated chemoprevention in colorectal carcinoma mouse model using proteomics analysis. _h[electronic resource] |
260 |
_bCarcinogenesis _cJul 2013 |
||
300 |
_a1575-84 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _a8-Hydroxy-2'-Deoxyguanosine |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aApoptosis |
650 | 0 | 4 |
_aAzoxymethane _xadverse effects |
650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
650 | 0 | 4 |
_aC-Reactive Protein _xmetabolism |
650 | 0 | 4 | _aChemoprevention |
650 | 0 | 4 |
_aColonic Polyps _xchemically induced |
650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aDeoxyguanosine _xanalogs & derivatives |
650 | 0 | 4 |
_aDextran Sulfate _xadverse effects |
650 | 0 | 4 |
_aDrug Screening Assays, Antitumor _xmethods |
650 | 0 | 4 | _aElectrophoresis, Gel, Two-Dimensional |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred ICR |
650 | 0 | 4 |
_aNeoplasm Proteins _xanalysis |
650 | 0 | 4 | _aOxidative Stress |
650 | 0 | 4 | _aProhibitins |
650 | 0 | 4 | _aProtein Interaction Maps |
650 | 0 | 4 |
_aProteome _xanalysis |
650 | 0 | 4 |
_aProteomics _xmethods |
650 | 0 | 4 |
_aRepressor Proteins _xgenetics |
650 | 0 | 4 |
_aSelenomethionine _xadministration & dosage |
650 | 0 | 4 | _aSoftware |
700 | 1 | _aSeo, Young Rok | |
773 | 0 |
_tCarcinogenesis _gvol. 34 _gno. 7 _gp. 1575-84 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/carcin/bgt078 _zAvailable from publisher's website |
999 |
_c22591432 _d22591432 |